Form 4: Amedisys Director Samuels Receives Stock Award

Director Ivanetta Davis Samuels received 1,678 restricted stock units from Amedisys Inc. on May 3, 2024, which will vest on May 3, 2025, contingent upon continued service on the Board of Directors.

Summary

• On May 3, 2024, Ivanetta Davis Samuels, a director of Amedisys Inc., was awarded 1,678 time-based Restricted Stock Units (RSUs).
• Each RSU represents a contingent right to receive one share of Amedisys' common stock.
• The RSUs will vest 100% on May 3, 2025, provided Samuels continues to serve as a non-employee member of the Board of Directors through that date.
• Following the transaction, Samuels beneficially owns 5,910 shares of Amedisys Inc. common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The granting of stock options to a director is a standard practice and generally viewed as a positive sign of aligning interests with shareholders. There are no red flags or negative information in the document.

Positives

• The awarding of RSUs to a director aligns their interests with those of the shareholders, incentivizing continued service and contribution to the company's success.

Future Outlook

The vesting of the RSUs is contingent upon the director's continued service, suggesting an expectation of ongoing board membership.

Industry Context

Stock awards are a common form of compensation for directors of publicly traded companies, aligning their interests with shareholders and incentivizing long-term value creation. This is a standard practice in the healthcare services industry, where attracting and retaining experienced board members is crucial for strategic oversight and governance.

Comparison to Industry Standards

• Director compensation packages often include a mix of cash retainers, meeting fees, and equity awards.
• Companies like LHC Group (now part of Optum) and Encompass Health typically grant equity awards to their directors as part of their overall compensation strategy.
• The size and vesting schedule of the RSU award are generally in line with industry practices for companies of similar size and market capitalization as Amedisys.

Stakeholder Impact

• Shareholders may view the stock award positively as it aligns the director's interests with the company's long-term performance.
• Employees are unlikely to be directly impacted by this transaction.

Key Dates